Pharmacokinetics and Pharmacodynamics — MCQs

A 57-year-old man receiving mechanical ventilation contracts pneumonia caused by Pseudomonas aeruginosa. The patient is given antibiotic therapy with ceftazidime and gentamicin. Assuming the half-life of gentamicin is 3 hours in this patient, what percentage of the initial dose will most likely remain in his body 6 hours later?

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 51: Glyceryl trinitrate is given by the sublingual route primarily due to which pharmacokinetic characteristic?

A. Short half-life in plasma
B. High hepatic first-pass metabolism (Correct Answer)
C. High bioavailability via the oral route
D. Extensive protein binding

Explanation: **Explanation:** **1. Why Option B is Correct:** Glyceryl trinitrate (GTN) undergoes **extensive hepatic first-pass metabolism** (nearly 90-100%). When taken orally, it is rapidly degraded by the enzyme *organic nitrate reductase* in the liver before it can reach the systemic circulation. By administering it via the **sublingual route**, the drug is absorbed directly through the buccal mucosa into the systemic venous circulation (superior vena cava), bypassing the portal circulation and the liver. This ensures rapid onset of action and therapeutic plasma concentrations. **2. Why Other Options are Incorrect:** * **Option A:** While GTN does have a short half-life (approx. 2–8 minutes), this is a reason for its short duration of action, not the primary reason for choosing the sublingual route over the oral route. * **Option C:** This is factually incorrect. GTN has **very low oral bioavailability** (less than 1%) due to the aforementioned first-pass effect. * **Option D:** Protein binding affects the distribution and free fraction of a drug but does not dictate the route of administration in the context of avoiding metabolic degradation. **3. NEET-PG High-Yield Pearls:** * **Emergency Use:** Sublingual GTN is the drug of choice for **acute anginal attacks** due to its rapid onset (1–3 minutes). * **Storage:** GTN is volatile and light-sensitive; it should be stored in tightly closed, dark glass containers. * **Other Bypass Routes:** Other routes that bypass first-pass metabolism include transdermal patches, intravenous, and (partially) rectal administration. * **Propranolol & Morphine:** These are other classic examples of drugs with high first-pass metabolism, though they are still given orally in higher doses.

Question 52: Maintenance dose of a drug is dependent on which pharmacokinetic parameter?

A. Half-life (Correct Answer)
B. Volume of distribution
C. Total body concentration
D. Loading dose

Explanation: The **Maintenance Dose (MD)** is the amount of drug administered at regular intervals to maintain a stable therapeutic concentration (Steady State) in the plasma [1, 2]. **Why Half-life is correct:** The maintenance dose is primarily governed by the **Clearance (CL)** of the drug [1]. According to the formula: $MD = \text{Target Concentration} \times \text{Clearance}$ [1]. Since Clearance is directly related to the **Elimination Half-life ($t_{1/2}$)** and inversely to the Volume of Distribution ($CL = 0.693 \times Vd / t_{1/2}$), the rate at which a drug is removed from the body (determined by its half-life) dictates how much drug must be replaced to maintain steady state [1]. In clinical practice, the dosing interval is often chosen based on the drug's half-life [1]. **Why other options are incorrect:** * **B. Volume of Distribution (Vd):** This parameter determines the **Loading Dose**, not the maintenance dose. Vd relates the total amount of drug in the body to the plasma concentration [1]. * **C. Total body concentration:** This is a state achieved by dosing, not a pharmacokinetic parameter that determines the dose itself. * **D. Loading Dose:** This is the initial higher dose given to rapidly achieve the target concentration (especially for drugs with long half-lives). It is independent of the maintenance dose [1]. **High-Yield NEET-PG Pearls:** * **Loading Dose** = $Target\ Concentration \times Vd$ [1] * **Maintenance Dose** = $Target\ Concentration \times Clearance$ [1] * It takes approximately **4 to 5 half-lives** to reach Steady State concentration ($C_{ss}$), regardless of the dose or frequency. * If a drug's clearance is reduced (e.g., renal failure), the **Maintenance Dose must be decreased**, but the Loading Dose remains the same.

Question 53: All of the following are true about biotransformation except?

A. It means chemical alteration of the drug in the body.
B. The primary site for drug metabolism is the liver.
C. Phase I biotransformation reactions are nonsynthetic.
D. Products of phase II biotransformation reactions are mostly active drug metabolites. (Correct Answer)

Explanation: **Explanation:** Biotransformation (metabolism) is the chemical alteration of a drug in the body, primarily aimed at converting lipid-soluble substances into water-soluble ones for easier excretion. **Why Option D is the Correct Answer (The False Statement):** Phase II reactions (Synthetic/Conjugation reactions) involve attaching an endogenous moiety (like glucuronic acid, sulfate, or glycine) to the drug. These reactions almost always result in **inactive, highly polar, and easily excretable metabolites**. While there are rare exceptions (e.g., Morphine-6-glucuronide is more active than morphine), the general rule is that Phase II inactivates the drug. **Analysis of Other Options:** * **Option A:** This is the literal definition of biotransformation. It involves structural changes via enzymes. * **Option B:** The **liver** is the primary organ for metabolism due to its high concentration of Cytochrome P450 enzymes. Other sites include the kidneys, lungs, and intestinal mucosa. * **Option C:** Phase I reactions are termed **"Nonsynthetic"** because they involve processes like oxidation, reduction, and hydrolysis which uncover or add a functional group without attaching a large molecule. **High-Yield Clinical Pearls for NEET-PG:** * **Phase I vs. Phase II:** Phase I (Functionalization) often uses CYP450 enzymes; Phase II (Conjugation) uses transferases. * **Microsomal Enzymes:** Located in the Smooth Endoplasmic Reticulum (e.g., CYP450, Glucuronosyltransferase). Note: Most Phase II enzymes are non-microsomal (cytosolic), **except Glucuronidation**. * **First-Pass Metabolism:** Drugs with high first-pass metabolism (e.g., Nitroglycerin, Propranolol, Lidocaine) have low oral bioavailability. * **Exception to Inactivation:** Morphine-6-glucuronide is a potent active metabolite formed via Phase II.

Question 54: What causes the rapid awakening from a single bolus dose of Propofol?

A. Redistribution (Correct Answer)
B. Excretion
C. Biotransformation
D. D-Methylation

Explanation: **Explanation:** The rapid recovery from a single bolus dose of Propofol is due to **Redistribution**, not metabolism or excretion. **1. Why Redistribution is Correct:** Propofol is a highly lipid-soluble drug. Upon intravenous administration, it rapidly reaches organs with high blood flow (the **vessel-rich group**), primarily the brain, leading to a quick induction of anesthesia. However, as plasma levels fall, the drug quickly moves out of the brain and "redistributes" into less vascular but high-capacity tissues like skeletal muscle and adipose tissue. Since the concentration in the brain drops below the therapeutic threshold, the patient awakens within 5–10 minutes, even though the drug is still present in the body. **2. Why Other Options are Incorrect:** * **Excretion:** Renal or biliary clearance is too slow to account for the immediate awakening (minutes) seen with Propofol. * **Biotransformation (Metabolism):** While Propofol is rapidly metabolized by the liver (glucuronidation), the rate of metabolism does not match the speed of recovery from a single bolus. Metabolism determines the *elimination* half-life, whereas redistribution determines the *distribution* half-life ($\alpha$-half-life). * **D-Methylation:** This is not a primary metabolic pathway for Propofol. **High-Yield Clinical Pearls for NEET-PG:** * **Context-Sensitive Half-Time:** While recovery from a *bolus* is due to redistribution, recovery from a *prolonged infusion* depends on metabolism, as peripheral tissues become saturated. * **Propofol Infusion Syndrome (PRIS):** A rare, fatal complication of long-term high-dose infusion characterized by metabolic acidosis, rhabdomyolysis, and cardiac failure. * **Drug of Choice:** Propofol is the preferred agent for Day Care Surgery due to its rapid recovery and anti-emetic properties.

Question 55: First pass metabolism is maximum with which route?

A. Oral (Correct Answer)
B. Subcutaneous
C. Rectal
D. Sublingual

Explanation: ### Explanation **1. Why Oral is the Correct Answer:** First-pass metabolism (presystemic elimination) refers to the metabolism of a drug in the gut wall or liver before it reaches the systemic circulation. When a drug is taken **orally**, it is absorbed from the gastrointestinal tract into the **portal venous system**. This carries the entire dose directly to the **liver**, the primary site of metabolic enzymes (Cytochrome P450). Consequently, drugs with high hepatic extraction ratios undergo significant degradation, drastically reducing their bioavailability. **2. Analysis of Incorrect Options:** * **Sublingual:** The drug is absorbed directly through the oral mucosa into the superior vena cava, bypassing the portal circulation entirely. This ensures rapid action and 100% avoidance of first-pass metabolism (e.g., Nitroglycerin). * **Subcutaneous:** This parenteral route involves absorption into the systemic capillaries/lymphatics, bypassing the GI tract and the liver. * **Rectal:** This route offers **partial bypass** (approximately 50%). The superior rectal vein drains into the portal system, but the middle and inferior rectal veins drain directly into the systemic circulation (internal iliac and internal pudendal veins). Thus, it has less first-pass effect than the oral route but more than sublingual. **3. High-Yield Clinical Pearls for NEET-PG:** * **Bioavailability (F):** Drugs with high first-pass metabolism have low oral bioavailability. * **Propranolol, Lidocaine, and Nitroglycerin** are classic examples of drugs with extensive first-pass metabolism. * **Liver Cirrhosis:** In patients with liver disease or portosystemic shunts, the first-pass effect is reduced, leading to potentially toxic levels of drugs like Propranolol or Morphine. * **Alternative Routes:** To bypass first-pass metabolism, drugs are administered via IV, IM, Transdermal, or Sublingual routes.

Question 56: A drug administered through which of the following routes undergoes high first-pass metabolism?

A. Oral (Correct Answer)
B. Sublingual
C. Intravenous (I.V.)
D. Intramuscular (I.M.)

Explanation: **Explanation:** **1. Why Oral is Correct:** The oral route is the most common route associated with high **first-pass metabolism** (presystemic metabolism). When a drug is swallowed, it is absorbed from the gastrointestinal tract into the **portal venous system**. Before reaching the systemic circulation, the drug must pass through the **liver**, which is the primary site for drug metabolism. If the liver enzymes (like Cytochrome P450) metabolize a significant fraction of the drug during this initial passage, its bioavailability is drastically reduced. **2. Why Incorrect Options are Wrong:** * **Sublingual:** Drugs absorbed through the buccal mucosa drain directly into the superior vena cava, bypassing the portal circulation and the liver. This ensures rapid action and higher bioavailability (e.g., Nitroglycerin). * **Intravenous (I.V.):** This route bypasses all absorption barriers and the liver initially, delivering 100% of the drug directly into the systemic circulation. * **Intramuscular (I.M.):** The drug is absorbed from the muscle capillaries into the systemic venous return, bypassing the portal system and avoiding first-pass metabolism. **3. High-Yield Clinical Pearls for NEET-PG:** * **Definition:** First-pass metabolism occurs in the gut wall, portal vein, and most significantly, the **liver**. * **Drugs with high first-pass metabolism:** Nitroglycerin (hence given sublingually), Propranolol, Lidocaine, Morphine, and Salbutamol. * **Rectal Route:** Only the upper part of the rectum drains into the portal system; the lower part drains into the systemic veins. Therefore, the rectal route **partially** bypasses first-pass metabolism (~50%). * **Bioavailability (F):** High first-pass metabolism leads to low bioavailability. It is calculated as: $F = \text{Fraction absorbed} \times (1 - \text{Extraction ratio})$.

Question 57: What is the half-life of intravenous oxytocin?

A. 3 minutes (Correct Answer)
B. 30 minutes
C. 3 hours
D. 45-60 minutes

Explanation: Oxytocin is a peptide hormone synthesized in the hypothalamus and released by the posterior pituitary. When administered intravenously, it has a **very short half-life of approximately 3 to 5 minutes** [1]. This rapid clearance occurs because oxytocin is quickly degraded by the enzyme **oxytocinase** (aminopeptidase), which is produced by the placenta and found in the liver and kidneys [1]. This short half-life is clinically significant as it allows for precise titration during labor induction; if uterine hyperstimulation occurs, stopping the infusion leads to a rapid decline in plasma levels and cessation of effect within minutes. Also, oxytocin acts through G protein-coupled receptors to contract uterine smooth muscle [1].

Question 58: Which of the following statements regarding transfer of drugs across the placenta is FALSE?

A. Transfer across the placenta is lesser in early pregnancy.
B. All drugs to some extent can cross the placenta except heparin and insulin.
C. Ion trapping of acidic drugs occurs in the placenta. (Correct Answer)
D. P–glycoprotein is present in the placenta.

Explanation: **Explanation:** The transfer of drugs across the placenta is governed by lipid solubility, molecular weight, and the pH gradient between maternal and fetal blood. **1. Why Option C is the Correct (False) Statement:** The fetal blood is slightly more **acidic** (pH ~7.3) than maternal blood (pH ~7.4). According to the pH partition hypothesis, **basic drugs** (like local anesthetics or opioids) cross the placenta in an uncharged state and become ionized in the relatively acidic fetal environment. Once ionized, they cannot diffuse back into the maternal circulation, leading to accumulation. This is known as **ion trapping of basic drugs**, not acidic drugs. Acidic drugs remain largely unionized in the maternal blood and do not "trap" in the fetus. **2. Analysis of Other Options:** * **Option A:** In early pregnancy, the placental membrane is thicker and the surface area is smaller. As pregnancy progresses, the membrane thins and surface area increases, making drug transfer **greater in late pregnancy** and lesser in early pregnancy. * **Option B:** Most drugs cross the placenta via simple diffusion. Large molecular weight substances like **Heparin** (high MW) and **Insulin** (large peptide) are notable exceptions that do not cross the placental barrier. * **Option D:** The placenta contains efflux transporters like **P-glycoprotein (P-gp)** and BCRP. These act as a protective mechanism by pumping certain xenobiotics and drugs back into the maternal circulation. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of Thumb:** Drugs with MW **<500 Daltons** cross easily; **>1000 Daltons** (like Heparin) do not. * **Warfarin vs. Heparin:** Warfarin is teratogenic (crosses placenta); Heparin is the anticoagulant of choice in pregnancy (does not cross). * **Local Anesthetics:** During labor, lidocaine (a weak base) can undergo ion trapping in the fetus, potentially leading to neonatal depression.

Question 59: Which of the following is an inducer of microsomal enzymes?

A. Phenobarbitone (Correct Answer)
B. Paracetamol
C. Digoxin
D. Penicillin

Explanation: ### Explanation **1. Why Phenobarbitone is Correct:** Phenobarbitone is a classic, potent **inducer of hepatic microsomal enzymes** (specifically the Cytochrome P450 system, such as CYP1A2, CYP2C9, and CYP3A4). Enzyme inducers work by increasing the synthesis of microsomal enzymes, leading to an accelerated metabolism of themselves (auto-induction) and other co-administered drugs. This typically results in decreased plasma concentrations and reduced therapeutic efficacy of the affected drugs (e.g., warfarin, oral contraceptives). **2. Why the Other Options are Incorrect:** * **Paracetamol:** It is a substrate for microsomal enzymes (metabolized into the toxic metabolite NAPQI) but does not act as an inducer or inhibitor of the system. * **Digoxin:** It is a cardiac glycoside primarily excreted unchanged by the kidneys (via P-glycoprotein). It does not significantly interact with hepatic microsomal enzymes. * **Penicillin:** Most penicillins are excreted unchanged in the urine via tubular secretion and do not modulate the CYP450 enzyme system. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Clinical Consequence:** If a patient on Warfarin starts Phenobarbitone, their INR will drop (due to increased metabolism of Warfarin), necessitating a dose increase. * **Non-Microsomal Enzymes:** Note that enzymes like **Alcohol dehydrogenase**, **Xanthine oxidase**, and **MAO** are non-microsomal and are generally *not* inducible. * **Phenobarbitone Special Use:** It is used in **Congenital Non-hemolytic Jaundice (Type II Crigler-Najjar syndrome)** because it induces the enzyme glucuronyl transferase, helping conjugate bilirubin.

Question 60: A 57-year-old man receiving mechanical ventilation contracts pneumonia caused by Pseudomonas aeruginosa. The patient is given antibiotic therapy with ceftazidime and gentamicin. Assuming the half-life of gentamicin is 3 hours in this patient, what percentage of the initial dose will most likely remain in his body 6 hours later?

A. 12.5%
B. 25% (Correct Answer)
C. 33%
D. 50%

Explanation: ### Explanation **1. Why the Correct Answer is Right:** The question tests the fundamental concept of **Half-life ($t_{1/2}$)**, which is the time required for the plasma concentration of a drug to decrease by 50%. * **Initial Dose:** 100% * **After 1 Half-life (3 hours):** The concentration drops by half. (100% $\div$ 2 = **50%**) * **After 2 Half-lives (6 hours):** The concentration drops by half again. (50% $\div$ 2 = **25%**) Since the patient’s $t_{1/2}$ is 3 hours, a 6-hour interval represents exactly **two half-lives**. Therefore, 25% of the initial dose remains in the body. **2. Why the Incorrect Options are Wrong:** * **Option A (12.5%):** This represents the amount remaining after **three** half-lives (3 $\times$ 3 = 9 hours). * **Option C (33%):** This is a distractor; drug elimination follows exponential (first-order) decay, not a simple linear division into thirds. * **Option D (50%):** This represents the amount remaining after only **one** half-life (3 hours). **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **First-Order Kinetics:** Most drugs (including Gentamicin) follow first-order kinetics, where a **constant fraction** of the drug is eliminated per unit time. * **Steady State:** It takes approximately **4 to 5 half-lives** for a drug to reach steady-state concentration or to be completely eliminated from the body. * **Gentamicin Dosing:** Gentamicin is an aminoglycoside excreted renally. In clinical practice, if a patient has renal impairment, the $t_{1/2}$ increases significantly, requiring dosage adjustment to prevent nephrotoxicity and ototoxicity. * **Synergy:** The combination of a Cell Wall Inhibitor (Ceftazidime) and a Protein Synthesis Inhibitor (Gentamicin) provides **synergistic bactericidal action** against *Pseudomonas*.

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free